Problemas relacionados con medicamentos que causan ingresos por urgencias en un hospital de alta complejidad

• Main Authors: Rosa Alexandra Calvo-Salazar, Maribel David, Carolina María Rodríguez-Naranjo, Martha Isabel Zapata-Mesa, Naira Yadira Valencia-Acosta
• Format: Article
• Language: English
• Published: Grupo Aula Médica 2018-11-01
• Series: Farmacia Hospitalaria
• Subjects: Medication errors; Pharmaceutical care; Public health
• Online Access: http://www.aulamedica.es/fh/pdf/10996.pdf
• ISSN: 1130-6343; 2171-8695

Objective: Determining hospital admissions prevalence associated with problems related to medicines in the emergency services of high complexity hospital; performing the pertinent pharmaceutical interventions. Method: Descriptive observational cross-sectional study. The medical records of the patients admitted to the emergency services were reviewed. Those that reported hospitalization due to problems related to medication were selected. These were classified according to the Third Consensus of Granada adaptation. A pharma-therapeutic profile was made to hospitalized patients; performing the necessary pharmaceutical interventions to avoid future medication related problems. Results: 3.8% of patients were included in the study. The problems related to medications had a preventability of 87.7% and the most frequent were those of need with 42.2%. A pharma-therapeutic profile was done to hospitalized patients (137). 150 pharmaceutical interventions were done, which had an acceptance of 95.3%. The most intervened risk was administering an unnecessary medication 62.7%. Conclusions: Lack of supervision and analysis of problems related to medication could cause therapeutic approach failure, therefore, health and life quality improvement of the patients is not achieve. The pharmaceutical chemist plays a fundamental role in the health care of patients, helping to the prevention and proper use of medicines. The Pharmaceutical Care program proves that it provides an invaluable contribution to public health service by improving the pharmacological safety of treatments, reducing costs and public health problems.